|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$92,046.75 |
3.01% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$83,813.41 |
2.74% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$77,766.11 |
2.54% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$76,187.00 |
2.49% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$74,595.78 |
2.44% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$72,469.58 |
2.37% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$72,014.40 |
2.36% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$71,158.23 |
2.33% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$71,246.72 |
2.33% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$70,873.72 |
2.32% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$70,381.20 |
2.30% |
| Waters Corporation |
WAT |
941848103 |
184 |
$69,975.20 |
2.29% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$69,602.36 |
2.28% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$68,937.92 |
2.25% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$68,651.34 |
2.25% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$68,518.90 |
2.24% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$68,058.86 |
2.23% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$67,232.29 |
2.20% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$65,798.44 |
2.15% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$65,885.40 |
2.15% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$63,201.90 |
2.07% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$63,130.96 |
2.06% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$62,098.68 |
2.03% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$62,127.45 |
2.03% |
| Steris Plc |
STE |
G8473T100 |
265 |
$61,270.65 |
2.00% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$60,812.70 |
1.99% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$60,558.96 |
1.98% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$60,154.20 |
1.97% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$60,109.68 |
1.97% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$59,278.70 |
1.94% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$58,959.40 |
1.93% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$58,301.66 |
1.91% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$57,939.96 |
1.90% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$57,451.53 |
1.88% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,929.74 |
1.86% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$56,441.58 |
1.85% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$56,526.38 |
1.85% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$54,914.70 |
1.80% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$53,808.48 |
1.76% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$53,101.27 |
1.74% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$52,525.66 |
1.72% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$52,329.52 |
1.71% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$49,704.00 |
1.63% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$46,346.71 |
1.52% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$45,886.10 |
1.50% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$45,005.41 |
1.47% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$43,930.00 |
1.44% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$42,575.39 |
1.39% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$41,735.79 |
1.37% |
| US Dollar |
$USD |
|
14,959 |
$14,959.26 |
0.49% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|